Literature DB >> 16843080

Brain volume regulation in response to hypo-osmolality and its correction.

Richard H Sterns1, Stephen M Silver.   

Abstract

Hyponatremia exerts most of its clinical effects on the brain. An acute onset (usually in <24 hours) of hyponatremia causes severe, and sometimes fatal, cerebral edema. Given time, the brain adapts to hyponatremia, permitting survival despite extraordinarily low serum sodium concentrations. Adaptation to severe hyponatremia is critically dependent on the loss of organic osmolytes from brain cells. These intracellular, osmotically active solutes contribute substantially to the osmolality of cell water and do not adversely affect cell functions when their concentration changes. The adaptation that permits survival in patients with severe, chronic (>48 hours' duration) hyponatremia also makes the brain vulnerable to injury (osmotic demyelination) if the electrolyte disturbance is corrected too rapidly. The reuptake of organic osmolytes after correction of hyponatremia is slower than the loss of organic osmolytes during the adaptation to hyponatremia. Areas of the brain that remain most depleted of organic osmolytes are the most severely injured by rapid correction. The brain's reuptake of myoinositol, one of the most abundant osmolytes, occurs much more rapidly in a uremic environment, and patients with uremia are less susceptible to osmotic demyelination. In an experimental model of chronic hyponatremia, exogenous administration of myoinositol speeds the brain's reuptake of the osmolyte and reduces osmotic demyelination and mortality caused by rapid correction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16843080     DOI: 10.1016/j.amjmed.2006.05.003

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  40 in total

Review 1.  Neurological counterparts of hyponatremia: pathological mechanisms and clinical manifestations.

Authors:  Manuel Alfredo Podestà; Irene Faravelli; David Cucchiari; Francesco Reggiani; Silvia Oldani; Carlo Fedeli; Giorgio Graziani
Journal:  Curr Neurol Neurosci Rep       Date:  2015-04       Impact factor: 5.081

2.  Profound hyponatremia in cirrhosis: a case report.

Authors:  Aaron Lindsay
Journal:  Cases J       Date:  2010-03-23

Review 3.  Vaptans for the treatment of hyponatremia.

Authors:  Gary L Robertson
Journal:  Nat Rev Endocrinol       Date:  2011-02-01       Impact factor: 43.330

4.  Astrocytes are an early target in osmotic demyelination syndrome.

Authors:  Fabrice Gankam Kengne; Charles Nicaise; Alain Soupart; Alain Boom; Johan Schiettecatte; Roland Pochet; Jean Pierre Brion; Guy Decaux
Journal:  J Am Soc Nephrol       Date:  2011-09-01       Impact factor: 10.121

Review 5.  Hyponatraemia - presentations and management.

Authors:  Rosemary Dineen; Christopher J Thompson; Mark Sherlock
Journal:  Clin Med (Lond)       Date:  2017-06       Impact factor: 2.659

6.  A bolus of conivaptan lowers intracranial pressure in a patient with hyponatremia after traumatic brain injury.

Authors:  Rajat Dhar; Theresa Murphy-Human
Journal:  Neurocrit Care       Date:  2011-02       Impact factor: 3.210

Review 7.  Sodium and fluid management in acute brain injury.

Authors:  Wendy L Wright
Journal:  Curr Neurol Neurosci Rep       Date:  2012-08       Impact factor: 5.081

8.  Clinical practice guideline on diagnosis and treatment of hyponatraemia.

Authors:  Goce Spasovski; Raymond Vanholder; Bruno Allolio; Djillali Annane; Steve Ball; Daniel Bichet; Guy Decaux; Wiebke Fenske; Ewout J Hoorn; Ewout Hoorn; Carole Ichai; Michael Joannidis; Alain Soupart; Robert Zietse; Maria Haller; Sabine van der Veer; Wim Van Biesen; Evi Nagler
Journal:  Intensive Care Med       Date:  2014-02-22       Impact factor: 17.440

9.  Osmotic Demyelination Syndrome Associated with Hypernatremia Caused by Lactulose Enema in a Patient with Chronic Alcoholism.

Authors:  Jeong Ho Lee; Chang Seong Kim; Eun Hui Bae; Soo Wan Kim; Seong Kwon Ma
Journal:  Electrolyte Blood Press       Date:  2021-06-30

10.  Potentiation by thrombin of hyposmotic glutamate and taurine efflux from cultured astrocytes: signalling chains.

Authors:  S Cruz-Rangel; R Hernández-Benítez; E Vázquez-Juárez; A López-Dominguez; H Pasantes-Morales
Journal:  Neurochem Res       Date:  2008-03-21       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.